Filter browse results

Subject: Health technologies > Diagnostics

As part of the Healthy Markets project, this technical update on HIV rapid diagnostic tests (RDTs) includes findings on why RDTs are important; how to apply new technologies in novel ways to address local needs; and it outlines regulatory review and quality assurance findings.

Soil-transmitted helminths (STHs) remain a massive global health problem. More robust, simple, and sensitive diagnostic tools will improve the ability of control programs to determine infection and response procedures. This document illustrates PATH’s contributions toward creating a business case for financing, developing, and deploying new diagnostics for detection of STH infection.

PATH seeks to assess diagnostic needs, survey potential solutions, and determine an appropriate strategy to identify the point in the cycle of trachoma transmission, infection, and elimination that would best be targeted for a new diagnostic technology and to articulate the business case for its development.

PATH collaborates with the US Department of Defense (DoD) to advance global health innovations. This fact sheet provides examples of successes that PATH, DoD, and our partners have had in working to adapt, test, and expand access to tools and technologies that can reduce illness in the world’s most vulnerable populations.

Hazard analysis critical control points (HACCP) planning is a critical step in ensuring the safety and quality of any food product, including donated and processed human milk. PATH developed this trainer’s guide and staff workbook to guide HACCP workshops in human milk banks.

PATH’s Center for Malaria Control and Elimination is building on our unparalleled portfolio of malaria tools and projects, encompassing a broad collection of competencies and expertise, to advance efforts toward elimination, and ultimately eradication, of both P. falciparum and P. vivax malaria.

GHTC is a group of 40 nonprofit organizations committed to increasing awareness of the urgent need for health technologies that save lives around the world. Breakthroughs highlights the news and stories that are driving the work we do to advance innovation to save lives.

This document describes a quality assurance (QA) program for Ov16 rapid tests that can be implemented by onchocerciasis control and elimination programs to help ensure high-quality testing and to identify areas for improvement and change. Designed for policymakers and program planners wishing to implement Ov16 rapid testing, these guidelines describe some important basic principles and the main practical aspects of a QA program.

Neglected tropical diseases (NTDs) infect over a billion people worldwide. PATH is working to identify and develop innovative, high-impact, low-cost diagnostic tools for NTDs for use in low-resource areas. This report outlines the process of developing target product profiles for three NTDs and includes summaries of findings.

This brochure describes the onchocerciasis surveillance rapid test SD BIOLINE Onchocerciasis IgG4. The test, developed to help onchocerciasis control and elimination programs by improving surveillance, is fast, easy to use, appropriate for field use, and minimally invasive.

PATH is a leader in the innovation, promotion, and adoption of diagnostic technologies to support malaria elimination and ultimately eradication. As a whole, malaria-related projects and programs at PATH form a core of organizational expertise and strong infrastructure to accelerate the development and adoption of new and improved malaria diagnostics.

Innovation for Global Health is the Global Health Technologies Coalition's e-newsletter focusing on the development and delivery of lifesaving health tools to people in need worldwide. The newsletter provides updates on the latest research and policy developments on innovative tools to prevent, diagnose, and treat diseases. It includes news from US agencies, Congress, the current administration, and the global health community at large.

PATH and the US Department of Health and Human Services (HHS) work together to protect and improve health in developing countries. This fact sheet provides examples of successes that PATH, HHS, and our partners have had in developing and deploying new global health technologies to prevent, detect, and control epidemic and neglected diseases, advance health research, and save lives around the world.

This brochure outlines PATH's work in China, with emphasis on public-private partnerships for product development. Areas of focus include vaccines and immunization, health technologies, and women's health.

This success story displays positive outcomes of PATH's work in the Democratic Republic of Congo related to the control and treatment of multidrug-resistant tuberculosis (MDR-TB), achieved by introducing the innovative GeneXpert diagnostic machine. This work was made possible with funding from the United States Agency for International Development.

This project brief describes PATH’s work in promoting tuberculosis (TB) control in India by building local and national capacities in advocacy, communication, and social mobilization (ACSM) strategies. This work aimed to improve TB case detection and treatment adherence by training local civil-society members and national-level staff to design and implement ACSM work plans. This project was made possible through support from the United States Agency for International Development.

This project brief describes PATH’s work in promoting tuberculosis (TB) control in India by contributing to health human resources development throughout the country. With support from the United States Agency for International Development, PATH worked with Initiatives Inc. to assess the state of human resources working in TB-related capacities in India, to analyze the feasibility of integrating the national TB program with the general health system, and to pilot an integrated model of TB programming within the general health system in four districts. The brief outlines lessons learned that can be applied to future health human resources development in TB-related capacities in India and globally.

As with many other diseases, the burden of breast cancer falls most heavily on poor, marginalized, and rural women due to their unequal access to screening and treatment. This fact sheet describes PATH and our partners’ novel approach to improving early detection, diagnosis, and care in La Libertad, Peru, using a health care model that can be expanded and applied to other low-resource settings.